Kaken Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 12, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	159,426	176,794	130,992	138,463	147,114	166,112
Market Cap Growth	-1.24%	34.97%	-5.40%	-5.88%	-11.44%	-15.14%
Enterprise Value	117,438	100,891	68,690	72,334	84,580	101,291
Last Close Price	4210.00	4370.72	3223.47	3301.76	3340.15	3595.09
PE Ratio	-	12.68	16.32	25.45	15.41	12.39
Forward PE	68.08	22.01	19.39	13.57	13.10	13.02
PS Ratio	2.11	1.88	1.82	1.90	1.94	2.22
PB Ratio	1.09	1.16	0.91	1.01	1.06	1.22
P/TBV Ratio	1.26	1.33	0.96	1.07	1.14	1.23
P/FCF Ratio	-	6.90	182.95	19.06	14.21	13.39
P/OCF Ratio	-	5.94	50.83	14.96	11.03	11.55
EV/Sales Ratio	1.55	1.07	0.95	0.99	1.11	1.35
EV/EBITDA Ratio	-	4.28	5.60	6.85	4.33	5.04
EV/EBIT Ratio	-	4.80	7.22	9.04	4.96	5.69
EV/FCF Ratio	-	3.94	95.94	9.96	8.17	8.16
Debt / Equity Ratio	0.03	0.03	0.03	0.03	0.03	0.03
Debt / EBITDA Ratio	-	0.16	0.31	0.36	0.20	0.19
Debt / FCF Ratio	-	0.15	5.38	0.53	0.37	0.31
Net Debt / Equity Ratio	-0.29	-0.43	-0.43	-0.51	-0.51	-0.54
Net Debt / EBITDA Ratio	29.44	-2.81	-5.01	-6.66	-3.62	-3.65
Net Debt / FCF Ratio	-	-2.58	-85.86	-9.69	-6.84	-5.92
Asset Turnover	-	0.52	0.43	0.44	0.46	0.47
Inventory Turnover	-	1.96	2.05	2.19	2.28	2.48
Quick Ratio	3.11	3.01	4.68	4.49	4.98	4.60
Current Ratio	4.09	3.67	5.62	5.27	5.81	5.34
Return on Equity (ROE)	-	9.41%	5.72%	3.95%	6.96%	10.13%
Return on Assets (ROA)	-	7.26%	3.52%	3.02%	6.49%	6.92%
Return on Invested Capital (ROIC)	-3.86%	17.90%	10.48%	9.53%	18.01%	20.99%
Return on Capital Employed (ROCE)	-2.50%	13.10%	6.20%	5.50%	11.70%	12.50%
Earnings Yield	-2.40%	7.89%	6.13%	3.93%	6.49%	8.07%
FCF Yield	-	14.50%	0.55%	5.25%	7.03%	7.47%
Dividend Yield	4.50%	3.43%	4.65%	4.54%	4.49%	4.17%
Payout Ratio	-	51.62%	70.49%	103.84%	59.84%	43.35%
Buyback Yield / Dilution	0.01%	-1.13%	-0.44%	1.07%	1.59%	1.41%
Total Shareholder Return	4.52%	2.31%	4.21%	5.62%	6.08%	5.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.